Noveayr Therapeutics

Noveayr Therapeutics, is a respiratory focused pharmaceutical company with an integrated development and manufacturing capability. Through its portfolio, IP and scientific expertise it is almost uniquely positioned to address respiratory disease from cause to consequence; helping eradicate one of its major causes in smoking, offering life changing treatments for asthma and COPD and addressing the environmental consequences of those treatments. It is a specialist in medicines delivered through propellant based pressurized metered dose inhalers (pMDIs). We are committed to changing over to the next generation green propellant capabilities with low global warming potential, through reformulating major existing products and enabling...

Inhalation,respiratory,cdmo,and breath-actuated devices

Noveayr therapeutics operates in the Pharmaceutical manufacturing industry.

Noveayr therapeutics's revenue is 11m - 100m

Noveayr therapeutics has 11 - 50 employees.